advertisement

WGA Rescources

Shen Y 17

Showing records 1 to 17 | Display all abstracts from Shen Y

119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Wei Q
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Singh IP
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Zhu C
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Berdahl JP; Sarkisian SR
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Yuan G
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Voskanyan LA
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Jin J; Zhang J
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Ang RE
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Fan W
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Doan LV; Doan LV
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Piao Y
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Applegate D; Shen Y
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Shao S
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Katz LJ
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Lin S; Xiang J
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Kothe AC; Navratil T
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Shen Y
Journal of Controlled Release 2025; 377: 578-590

Issue 25-1

Change Issue


advertisement

WGA Rescources